Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model

References

• World Health Organization. Weekly epidemiological update – 28 December 2021. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20211228_weekly_epi_update_72.pdf?sfvrsn = 7a3567d4_3&download = true.
   Google Scholar
• Abdel-Moneim AS, Abdelwhab EMJP. Evidence for SARS-CoV-2 infection of animal hosts. Pathogens. 2020;9(7):529.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8(12):1201–1208. doi:10.1016/S2213-2600(20)30370-2. PubMed PMID: 32861276; PubMed Central PMCID: PMCPMC7834127.
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001. PubMed PMID: 32513566; PubMed Central PMCID: PMCPMC7265853.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-9. PubMed PMID: 31986261; PubMed Central PMCID: PMCPMC7159286.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–164. doi:10.3947/ic.2020.52.2.154. PubMed PMID: WOS:000546188600003; English.
   PubMed Web of Science ®Google Scholar
• Heald-Sargent T, Muller WJ, Zheng XT, et al. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate Coronavirus Disease 2019 (COVID-19). Jama Pediatr. 2020;174(9):902–903. doi:10.1001/jamapediatrics.2020.3651. PubMed PMID: WOS:000571868200025; English.
   PubMed Web of Science ®Google Scholar
• O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–145. doi:10.1038/s41586-020-2918-0.
   PubMed Web of Science ®Google Scholar
• Nikolich-Zugich J, Knox KS, Rios CT, et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42(3):1013–1013. doi:10.1007/s11357-020-00193-1. PubMed PMID: WOS:000530257000001; English.
   PubMed Web of Science ®Google Scholar
• Shuai H, Chan JF, Yuen TT, et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine. 2021 Oct 21;73:103643. doi:10.1016/j.ebiom.2021.103643. PubMed PMID: 34689086; PubMed Central PMCID: PMCPMC8530107.
   PubMed Web of Science ®Google Scholar
• Chan JF, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020;71:2428–2446. doi:10.1093/cid/ciaa325. PubMed PMID: 32215622.
   PubMed Web of Science ®Google Scholar
• Li C, Chen Y, Zhao Y, et al. Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis. 2021;73:2372–2373. doi:10.1093/cid/ciab707. PubMed PMID: 34406358; PubMed Central PMCID: PMCPMC8436386.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yip CC, To KK, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated In vitro and with Clinical specimens. J Clin Microbiol. 2020;58(5). doi:10.1128/JCM.00310-20. PubMed PMID: 32132196; PubMed Central PMCID: PMCPMC7180250.
   Web of Science ®Google Scholar
• Chu H, Chan JF-W, Yuen TT-T, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1:e14–e23. doi:10.1016/s2666-5247(20)30004-5.
   PubMedGoogle Scholar
• Yuan S, Wang R, Chan JF, et al. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat Microbiol. 2020;5(11):1439–1448. doi:10.1038/s41564-020-00802-x. PubMed PMID: 33028965.
   PubMed Web of Science ®Google Scholar
• Lee AC, Zhang AJ, Chan JF, et al. Oral SARS-CoV-2 inoculation establishes subclinical respiratory infection with virus shedding in Golden Syrian hamsters. Cell Rep Med. 2020;1(7):100121. doi:10.1016/j.xcrm.2020.100121. PubMed PMID: 32984855; PubMed Central PMCID: PMCPMC7508015.
   PubMedGoogle Scholar
• Chan JF, Poon VK, Chan CC, et al. Low environmental temperature exacerbates severe acute respiratory syndrome coronavirus 2 infection in Golden Syrian hamsters. Clin Infect Dis. 2021. doi:10.1093/cid/ciab817. PubMed PMID: 34536277.
   Web of Science ®Google Scholar
• Zhang AJX, Zhu H, Chen Y, et al. Prostaglandin E2-mediated impairment of innate immune response to A(H1N1)pdm09 infection in diet-induced obese mice could be restored by paracetamol. J Infect Dis. 2019;219:795–807. doi:10.1093/infdis/jiy527. PubMed PMID: 30202973.
   PubMed Web of Science ®Google Scholar
• Li C, To KKW, Zhang AJX, et al. Co-stimulation with TLR7 agonist imiquimod and inactivated influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production. Front Immunol. 2018 Oct 12;9, doi:10.3389/fimmu.2018.02370. PubMed PMID: WOS:000447130500001; English.
   Web of Science ®Google Scholar
• Lee AC, Zhu H, Zhang AJ, et al. Suboptimal humoral immune response against influenza A(H7N9) virus Is related to its internal genes. Clin Vaccine Immunol. 2015;22(12):1235–1243.
   PubMedGoogle Scholar
• Perera RA, Mok CK, Tsang OT, et al. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), march 2020. Euro Surveill. 2020;25(16):2000421. doi:10.1128/CVI.00443-15. PubMed PMID: 26446420; PubMed Central PMCID: PMCPMC4658586.
   PubMedGoogle Scholar
• Zhang AJ, Li C, To KK, et al. Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice. Clin Vaccine Immunol. 2014;21(4):570–579. doi:10.1128/CVI.00816-13. PubMed PMID: 24521786; PubMed Central PMCID: PMCPMC3993121.
   PubMed Web of Science ®Google Scholar
• Zhou R, To KK-W, Wong Y-C, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53(4):864–877.e5. doi:10.1016/j.immuni.2020.07.026.
   PubMed Web of Science ®Google Scholar
• Zhang AJ, Lee AC, Chu H, et al. Severe acute respiratory syndrome coronavirus 2 infects and damages the mature and immature olfactory sensory neurons of hamsters. Clin Infect Dis. 2021;73(2):e503–e512. doi:10.1093/cid/ciaa995. PubMed PMID: 32667973; PubMed Central PMCID: PMCPMC7454453.
   PubMed Web of Science ®Google Scholar
• Li C, Chen YX, Liu FF, et al. Absence of vaccine-enhanced disease with unexpected positive protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inactivated vaccine given within 3 days of virus challenge in Syrian Hamster model. Clin Infect Dis. 2021;73(3):e719–e734. doi:10.1093/cid/ciab083. PubMed PMID: 33515458; PubMed Central PMCID: PMCPMC7929057.
   PubMed Web of Science ®Google Scholar
• Kõks S, Dogan S, Tuna BG, et al. Mouse models of ageing and their relevance to disease. Mech Ageing Dev. 2016;160:41–53. doi:10.1016/j.mad.2016.10.001.
   PubMed Web of Science ®Google Scholar
• Pinchuk LM, Filipov NM. Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing. 2008;5(1):1. doi:10.1186/1742-4933-5-1.
   PubMedGoogle Scholar
• Johansen M, Irving A, Montagutelli X, et al. Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunol. 2020;13(6):877–891.
   PubMed Web of Science ®Google Scholar
• Yu P, Qi F, Xu Y, et al. Age-related rhesus macaque models of COVID-19. Anim Models Exp Med. 2020;3(1):93–97. doi:10.1002/ame2.12108. PubMed PMID: 32318665; PubMed Central PMCID: PMCPMC7167234. eng.
   PubMedGoogle Scholar
• Natoli S, Oliveira V, Calabresi P, et al. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020;27(9):1764–1773. doi:10.1111/ene.14277.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang K, Wang T, et al. SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia. J Virol. 2021;95(11):e02477-20.
   PubMed Web of Science ®Google Scholar
• Rathnasinghe R, Jangra S, Cupic A, et al. The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera. medRxiv. 2021. doi:10.1101/2021.01.19.21249592.
   Google Scholar
• To KK-W, Hung IF-N, Ip JD, et al. Coronavirus disease 2019 (COVID-19) re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2021;73(9):e2946–e2951. doi:10.1093/cid/ciaa1275.
   PubMed Web of Science ®Google Scholar
• Seow J, Graham C, Merrick B, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. Nat Microbiol. 2020;5(12):1598. doi:10.1038/s41564-020-00813-8.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577. PubMed PMID: 33301246; PubMed Central PMCID: PMCPMC7745181.
   PubMed Web of Science ®Google Scholar
• Kalnin KV, Plitnik T, Kishko M, et al. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models. NPJ Vaccines. 2021;6(1):61. doi:10.1038/s41541-021-00324-5. PubMed PMID: 33875658; PubMed Central PMCID: PMCPMC8055913.
   PubMed Web of Science ®Google Scholar
• DiPiazza AT, Leist SR, Abiona OM, et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity. 2021 Aug 10;54(8):1869–1882.e6. doi:10.1016/j.immuni.2021.06.018. PubMed PMID: 34270939; PubMed Central PMCID: PMCPMC8249710.
   PubMed Web of Science ®Google Scholar
• Hikono H, Kohlmeier JE, Ely KH, et al. T-cell memory and recall responses to respiratory virus infections. Immunol Rev. 2006;211:119–132. doi:10.1111/j.0105-2896.2006.00385.x. PubMed PMID: 16824122.
   PubMed Web of Science ®Google Scholar
• Bergwerk M, Gonen T, Lustig Y, et al. COVID-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021;385(16):1474–1484.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176(10):6333. doi:10.4049/jimmunol.176.10.6333.
   PubMed Web of Science ®Google Scholar
• Libster R, Pérez Marc G, Wappner D, et al. Early high-titer plasma therapy to prevent severe COVID-19 in older adults. N Engl J Med. 2021;384(7):610–618. doi:10.1056/NEJMoa2033700.
   PubMed Web of Science ®Google Scholar
• Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020;12(10):9959–9981. doi:10.18632/aging.103344. PubMed PMID: 32470948; PubMed Central PMCID: PMCPMC7288963. eng.
   PubMedGoogle Scholar